Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions


Creative Commons License

Koehler S. M., Buyuk F., Celebi O., Demiraslan H., DOĞANAY M., Sahin M., ...More

BMC VETERINARY RESEARCH, vol.13, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 13
  • Publication Date: 2017
  • Doi Number: 10.1186/s12917-017-1140-2
  • Journal Name: BMC VETERINARY RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: Bacillus anthracis, Anthrax, Vaccination, Animal vaccine, COMPARATIVE EFFICACY, SUBOPTIMAL AMOUNTS, GUINEA-PIGS, VACCINE, ANTIGEN, MICE, IMMUNIZATION, PROTEIN, STRAINS, TOXIN
  • Lokman Hekim University Affiliated: No

Abstract

Background: Bacillus (B.) anthracis, the causal agent of anthrax, is effectively controlled by the Sterne live spore vaccine (34F2) in animals. However, live spore vaccines are not suitable for simultaneous vaccination and antibiotic treatment of animals being at risk of infection in an outbreak situation. Non-living vaccines could close this gap.